IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial. - Fleischhack,G.; Hasan,C.; Graf,N.; Mann,G.; Bode,U. (Br J Haematol, 1998)